External Collaborative Research Grant: Major Depressive Disorder
External Collaborative Research (ECR)
The External Collaborative Research (ECR) program is open to all qualified academic and community-based scientists or consortia that are interested in proposing a study and wish to collaborate with Boehringer Ingelheim to develop a protocol and analyze and publish the results.
In addition to providing intellectual contributions, Boehringer Ingelheim may provide drug and/or financial support for an ECR. Boehringer Ingelheim does not serve as the regulatory sponsor for an ECR.
-
Evaluate patient assessment, symptom evaluation, and diagnosis patterns
-
Assess the treatment landscape and trajectory of disease progression
The preliminary budget for ECRs should reflect fair market value for all costs and cannot include direct
salary support for the principal investigator. Budgets for ECRs will be further negotiated pending
finalization of the collaborative protocol.
Although the research interests listed within the therapeutic areas are of focus to Boehringer Ingelheim,
other research interests may be considered.
PIRA™ proposals are AI generated and are not reviewed or endorsed by the sponsoring company.